A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis
Status:
Completed
Trial end date:
2020-10-08
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to investigate if KY1005 results in improvement of
eczema when given to participants with moderate to severe disease. Side effects of KY1005
will also be explored.